Botanical guide · Ingredient reference

Saffron and coagulation tests: a short null trial is not an interaction clearance

A healthy-volunteer study found no differences in selected coagulation measures after seven days. It did not test prevention of clots or compatibility with anticoagulant medicines.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

Study and results

Sixty adults were divided among placebo and two saffron-tablet groups in a double-blind study. Blood was sampled before treatment, after a week and again one month later. [1]

The measured panel included fibrinogen, factor VII, proteins C and S, prothrombin time and partial thromboplastin time. None showed a significant difference between groups. [1]

Interpretation and limitations

A laboratory panel in healthy volunteers does not capture every platelet effect or clinical bleeding event. The short duration also limits long-term inference. Funding and conflicts were not established from the abstract; the findings do not support using saffron as a blood thinner. [1]

A hypothetical distinction

Imagine several clotting tests remain unchanged. That answers the tests’ question under those conditions, not every possible medication interaction.

Evidence summary — Saffron and coagulation tests
DetailInterpretation
Selected laboratory testsNo group difference
Clinical clot preventionNot measured
Anticoagulant combinationNot tested
Saffron and coagulation tests: a short null trial is not an interaction clearance — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Effect of Crocus sativus L. (saffron) on coagulation and anticoagulation systems in healthy volunteers - PubMed
    Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.